Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Industry / Manufacturing/  FDA bans imports from canadian drugmaker Apotex’s India plant
BackBack

FDA bans imports from canadian drugmaker Apotex’s India plant

The FDA has stepped up scrutiny of medicines made in India, which supplies about 40% of generic and over-the-counter drugs to the US

The ban on Apotex’s factory comes after manufacturing plants of top Indian drugmakers like Ranbaxy Laboratories Ltd , Wockhardt Ltd and Sun Pharmaceutical Industries Ltd were barred from exporting to the United States due to quality concerns. Photo: BloombergPremium
The ban on Apotex’s factory comes after manufacturing plants of top Indian drugmakers like Ranbaxy Laboratories Ltd , Wockhardt Ltd and Sun Pharmaceutical Industries Ltd were barred from exporting to the United States due to quality concerns. Photo: Bloomberg

Mumbai: The US Food and Drug Administration banned imports from Canadian drugmaker Apotex Inc’s manufacturing plant in India for not complying with quality standards, the latest in a series of sanctions against medicines produced in India.

Drugs made at the plant, based in Bangalore, will be detained without physical examination because the factory did not meet the FDA’s good manufacturing practices, the agency said on its website on Wednesday.

The ban excludes Riluzole, a drug used to treat amyotrophic lateral sclerosis, commonly called Lou Gehrig’s disease.

The ban on Apotex’s factory comes after manufacturing plants of top Indian drugmakers like Ranbaxy Laboratories Ltd , Wockhardt Ltd and Sun Pharmaceutical Industries Ltd were barred from exporting to the United States due to quality concerns.

The FDA has stepped up scrutiny of medicines made in India, which supplies about 40% of generic and over-the-counter drugs to the US.

FDA Commissioner Margaret Hamburg in February said the agency was not unduly targeting drug companies in India, but “undertaking our required regulatory activities" needed to protect public health in the United States.

Apotex currently makes about 260 generic drugs, or copies of name-brand pharmaceutical products, that are sold in Canada and exported to more than 115 countries. The company’s sales exceed C$1 billion a year, according to its website.

Ontario-based Apotex was not available to comment outside of regular business hours and calls to its Bangalore research facility went unanswered. Reuters

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Industry News, Banking News and Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Published: 03 Apr 2014, 04:15 PM IST
Next Story footLogo
Recommended For You
Manufacturing Stocks
₹557.550.52%
ITC
₹4280.13%
₹2,987.85-0.37%
₹152.852%
Switch to the Mint app for fast and personalized news - Get App